Literature DB >> 1646640

Involvement of endogenously produced 1,25-dihydroxyvitamin D-3 in the growth and differentiation of human keratinocytes.

K Matsumoto1, Y Azuma, M Kiyoki, H Okumura, K Hashimoto, K Yoshikawa.   

Abstract

In this study, we investigated the possibility that cultured keratinocytes from normal human adult skin produce 1,25-dihydroxyvitamin D-3 (1,25(OH)2D3, a biologically active form of vitamin D-3) from 25-hydroxyvitamin D-3 [25(OH)D3], and that 1,25(OH)2D3 endogenously produced by keratinocytes is involved in the self regulation of their growth and differentiation. To determine whether 1,25(OH)2D3 is produced from 25(OH)D3 by skin keratinocytes, 25(OH)[3H]D3 was added to keratinocyte cultures and incubated for 1 h and 5 h. The intracellular and extracellular metabolites were analyzed by three chromatographic systems. The three chromatograms revealed that the major metabolite produced from 25(OH)D3 was 1,25(OH)2D3. Most of the 1,25(OH)2D3 endogenously produced from 25(OH)D3 remained within the cells. To examine the time course of 1,25(OH)2D3 production, the amount of 1,25(OH)[3H]D3 was measured at 15 min, 1 h, 5 h and 10 h, being at a maximum 1 h after the addition of 25(OH)D3. These data indicate that keratinocytes rapidly convert 25(OH)D3 to 1,25(OH)2D3 and that 1,25(OH)2D3 is not released into the medium. To determine whether endogenously produced 1,25(OH)2D3 is involved in the regulation of growth and differentiation of normal human keratinocytes, we examined the effects of 1,25(OH)2D3 and 25(OH)D3 on their growth and differentiation. Keratinocyte growth was inhibited to 52.6% and 23.4% by 10(-8) M and 10(-7) M 1,25(OH)2D3 and to 80.5% and 23.9% by 10(-8) M and 10(-7) M 25(OH)D3, respectively. Differentiation of these cells was evaluated by quantifying the number which express involucrin, a precursor protein of cornified envelope. The population of involucrin expressing cells (differentiated cells) increased from 6.2% to 14.5% by 2.5.10(-7) M 1,25(OH)2D3, and to 11.8% by 2.5.10(-7) M 25(OH)D3. These results clearly indicate that 25(OH)D3 is as effective on human keratinocytes as 1,25(OH)2D3 in inhibiting growth and inducing differentiation, although to a slightly lesser extent than 1,25(OH)2D3. The possibility that the effect of 25(OH)D3 is mediated through binding to the 1,25(OH)2D3 receptor can be excluded, since a competitive binding assay revealed that the affinity of 25(OH)D3 for the 1,25(OH)2D3 receptor in a cytosolic extract of keratinocytes was 100-times lower than that of 1,25(OH)2D3. Thus, these results suggest that 1,25(OH)2D3 endogenously produced in keratinocytes from 25(OH)D3 is involved in the regulation of their growth and differentiation in vitro.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1646640     DOI: 10.1016/s0167-4889(97)90006-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  CYP27B1 null mice with LacZreporter gene display no 25-hydroxyvitamin D3-1alpha-hydroxylase promoter activity in the skin.

Authors:  Janeen L Vanhooke; Jean M Prahl; Christine Kimmel-Jehan; Monica Mendelsohn; Eric W Danielson; Kevin D Healy; Hector F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-21       Impact factor: 11.205

2.  In vivo microautoradiography of [3H]1,24(OH)2D3 (tacalcitol) following topical application to normal rats and in vitro metabolism in human keratinocytes.

Authors:  T Ohta; K Okabe; Y Azuma; M Kiyoki
Journal:  Arch Dermatol Res       Date:  1996-04       Impact factor: 3.017

Review 3.  Vitamin D metabolism and function in the skin.

Authors:  Daniel D Bikle
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

4.  Effects of vitamin D and retinoic acid on human glioblastoma cell lines.

Authors:  L Magrassi; G Butti; S Pezzotta; L Infuso; G Milanesi
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

Review 5.  Targeting the vitamin D endocrine system (VDES) for the management of inflammatory and malignant skin diseases: An historical view and outlook.

Authors:  Jörg Reichrath; Christos C Zouboulis; Thomas Vogt; Michael F Holick
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

6.  Antiproliferative effects of the biologically active metabolite of vitamin D3 (1,25 [OH]2 D3) on head and neck squamous cell carcinoma cell lines.

Authors:  J Kornfehl; M Formanek; A Temmel; B Knerer; M Willheim
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

Review 7.  [New relevance of vitamin D3 metabolism in the skin].

Authors:  B Lehmann; K Querings; J Reichrath
Journal:  Hautarzt       Date:  2004-05       Impact factor: 0.751

8.  Selective sweep for an enhancer involucrin allele identifies skin barrier adaptation out of Africa.

Authors:  Mary Elizabeth Mathyer; Erin A Brettmann; Alina D Schmidt; Zane A Goodwin; Inez Y Oh; Ashley M Quiggle; Eric Tycksen; Natasha Ramakrishnan; Scot J Matkovich; Emma Guttman-Yassky; John R Edwards; Cristina de Guzman Strong
Journal:  Nat Commun       Date:  2021-05-07       Impact factor: 14.919

9.  Adjuvanting Allergen Extracts for Sublingual Immunotherapy: Calcitriol Downregulates CXCL8 Production in Primary Sublingual Epithelial Cells.

Authors:  Michael P Pelst; Clara Höbart; Charlotte Wallaeys; Hilde De Rooster; Yannick Gansemans; Filip Van Nieuwerburgh; Bert Devriendt; Eric Cox
Journal:  Front Immunol       Date:  2020-06-09       Impact factor: 7.561

10.  Mitochondrial translocation of vitamin D receptor is mediated by the permeability transition pore in human keratinocyte cell line.

Authors:  Francesca Silvagno; Marco Consiglio; Valentina Foglizzo; Michele Destefanis; Gianpiero Pescarmona
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.